CCT2 and Alzheimer disease: CCT2 expression, in contrast, was significantly reduced in various brain regions, including the entorhinal cortex, hippocampus, frontal cortex, and frontal cortex, providing further evidence that low CCT2 expression is one of the mechanisms of AD pathogenesis.